[Department of Error] Department of Error

Serruys PW, Chevalier B, Sotomi Y, et al. Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial. Lancet 2016; 388: 2479–91—In the appendix of this Article, table 1, footnotes clarifying the information on post-procedure intravascular ultrasound for patient 100 609-1002 and incomplete stent/scaffold apposition for patients 118 501–1006 and 120 314–1001 have been added.

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2lwLh1E
via IFTTT